ARCHIVES

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

Cancer Planners Revise Some Project Areas, Drop Some, Add New Ones

February 8, 1974

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

Seer Gets Concept Approve For Five More Years From Ad Hoc Committee Since Two PLs Are DCPC Board Members

February 3, 1984

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984

In Brief: Cancer Bill Nearly Became Law Without Nixon’s Signature as Impeachment Obsesses White House

August 2, 1974

Proposed Guidelines For Clinical Tests Of Oncologic Drugs

November 28, 1975